A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma
NCT00412828
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
117
Enrollment
INDUSTRY
Sponsor class
Conditions
Unresectable Stage III or Stage IV Melanoma
Interventions
DRUG:
CR011-vcMMAE
Sponsor
CuraGen Corporation